Reversal of left ventricular hypertrophy (LVH) in hypertensive patients appears to be a desirable goal to the reduction cardiac risk. The Renin-Angiotensin System (RAS) seems to play a major role in the establishment and maintenance of LVH through the activated systemic RAS and the Intracardiac Angiotensin System (IAS). We focused on the effects of a three-year treatment with losartan supplement in hypertensive patients with LVH not responding to eight years of an effective previous antihypertensive pharmacological treatment.
|Titolo:||Effects of losartan on left ventricular mass. a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment|
MORONI, Carlo (Corresponding author)
|Data di pubblicazione:||2017|
|Appartiene alla tipologia:||01l Trial clinico|